|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2995 SEK | -1.80% |
|
-15.87% | -86.51% |
| 03-11 | Duearity Unit Signs US Distribution Deal With Westone Laboratories | MT |
| 03-10 | Duearity Americas Inc Enters into an Agreement with Westone Laboratories | CI |
Duearity AB (publ) reported earnings results for the second quarter ended June 30, 2023. For the second quarter, the company reported sales was SEK 0.258 million. Revenue was SEK 0.258 million.
Net loss was SEK 6.27 million. Basic loss per share from continuing operations was SEK 0.37.
| 1st Jan change | Capi. | |
|---|---|---|
| -86.51% | 749K | |
| -9.49% | 28.16B | |
| +25.35% | 8.33B | |
| +33.25% | 4.39B | |
| -35.85% | 2.43B | |
| -9.44% | 1.6B | |
| -13.39% | 1.5B | |
| -32.84% | 1.15B | |
| +7.80% | 964M | |
| -37.56% | 872M |
DUEARITY AB 
